View Single Post
Old 08-02-2023, 08:28 PM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 20,149
Novel strategy can potentially control MAPK4-promoted growth in triple negative breas

In 2022, a team of researchers at Baylor College of Medicine discovered that a little-known enzyme called MAPK4 is involved in the growth of triple negative breast cancer (TNBC) and its resistance to certain therapies.

More...
News is offline   Reply With Quote